Quanterix Corporation Research and Development Expense
Quanterix Corporation (QTRX) reported Research and Development Expense of $7.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- Quanterix Corporation research and development expense for the quarter ending 2026-06-30 was $7.82M, a 13.88% decline year-over-year.
- Quanterix Corporation research and development expense for the quarter ending 2026-03-31 was $7.32M, a 27.03% decline year-over-year.
- Quanterix Corporation research and development expense for the quarter ending 2025-12-31 was $8.80M, a 9.04% increase year-over-year.
- Quanterix Corporation research and development expense for the quarter ending 2025-09-30 was $8.01M, a 1.17% decline year-over-year.
- Quanterix Corporation research and development expense for fiscal 2025 was $35.92M, a 15.57% increase from fiscal 2024.
- Quanterix Corporation research and development expense for fiscal 2024 was $31.08M, a 19.25% increase from fiscal 2023.
- Quanterix Corporation research and development expense for fiscal 2023 was $26.06M, a 2.78% decline from fiscal 2022.
- Quanterix Corporation research and development expense for fiscal 2022 was $26.81M, a 5.55% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.82M 10-Q · filed 2026-08-10 | $15.14M 10-Q · filed 2026-08-10 | $23.94M derived: sum of 3 quarters · filed 2026-08-10 | $31.95M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $7.32M 10-Q · filed 2026-05-06 | $16.12M derived: sum of 2 quarters · filed 2026-05-06 | $24.13M derived: sum of 3 quarters · filed 2026-05-06 | $33.21M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $16.80M derived: sum of 2 quarters · filed 2026-03-02 | $25.89M derived: sum of 3 quarters · filed 2026-08-10 | $35.92M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $8.01M 10-Q · filed 2025-11-10 | $17.09M derived: sum of 2 quarters · filed 2026-08-10 | $27.13M 10-Q · filed 2025-11-10 | $35.19M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $9.08M 10-Q · filed 2026-08-10 | $19.12M 10-Q · filed 2026-08-10 | $27.18M derived: sum of 3 quarters · filed 2026-08-10 | $35.29M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $10.04M 10-Q · filed 2026-05-06 | $18.10M derived: sum of 2 quarters · filed 2026-05-06 | $26.21M derived: sum of 3 quarters · filed 2026-05-06 | $34.38M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $16.17M derived: sum of 2 quarters · filed 2026-03-02 | $24.34M derived: sum of 3 quarters · filed 2026-03-02 | $31.08M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $8.10M 10-Q · filed 2025-11-10 | $16.27M derived: sum of 2 quarters · filed 2025-11-10 | $23.02M 10-Q · filed 2025-11-10 | $30.23M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $8.17M 10-Q · filed 2025-08-07 | $8.10M 10-Q · filed 2024-08-08 | $14.91M 10-Q · filed 2025-08-07 | $14.78M 10-Q · filed 2024-08-08 | $22.12M derived: sum of 3 quarters · filed 2025-08-07 | $29.86M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $6.74M 10-Q · filed 2025-05-12 | $6.67M 10-Q · filed 2024-05-08 | $13.95M derived: sum of 2 quarters · filed 2025-05-12 | $21.69M derived: sum of 3 quarters · filed 2025-05-12 | $27.82M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $7.21M 10-K/A · filed 2024-12-26 | $14.95M derived: sum of 2 quarters · filed 2024-12-26 | $21.08M derived: sum of 3 quarters · filed 2024-12-26 | $26.06M 10-K · filed 2026-03-02 | $24.86M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $7.74M 10-K/A · filed 2024-12-26 | $7.20M 10-Q · filed 2023-11-08 | $13.87M derived: sum of 2 quarters · filed 2024-12-26 | $18.85M 10-K/A · filed 2024-12-26 | $17.87M 10-Q · filed 2023-11-08 | $24.70M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-06-30 | $6.13M 10-K/A · filed 2024-12-26 | $5.95M 10-Q · filed 2023-08-08 | $11.12M 10-K/A · filed 2024-12-26 | $10.67M 10-Q · filed 2023-08-08 | $16.96M derived: sum of 3 quarters · filed 2024-12-26 | $23.79M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-03-31 | $4.99M 10-K/A · filed 2024-12-26 | $4.72M 10-Q · filed 2023-05-09 | $10.83M derived: sum of 2 quarters · filed 2024-12-26 | $17.66M derived: sum of 3 quarters · filed 2024-12-26 | $24.92M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2022-12-31 | $5.84M 10-K/A · filed 2024-12-26 | $12.67M derived: sum of 2 quarters · filed 2024-12-26 | $19.93M derived: sum of 3 quarters · filed 2024-12-26 | $26.81M 10-K · filed 2025-03-17 | $25.89M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $6.83M 10-K/A · filed 2024-12-26 | $6.63M 10-Q · filed 2022-11-09 | $14.09M derived: sum of 2 quarters · filed 2024-12-26 | $20.97M 10-K/A · filed 2024-12-26 | $20.29M 10-Q · filed 2022-11-09 | $29.11M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | $7.26M 10-K/A · filed 2024-12-26 | $6.63M 10-Q · filed 2022-08-08 | $14.14M 10-K/A · filed 2024-12-26 | $13.66M 10-Q · filed 2022-08-08 | $22.28M derived: sum of 3 quarters · filed 2024-12-26 | $29.08M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | $6.88M 10-K/A · filed 2024-12-26 | $7.03M 10-Q · filed 2022-05-10 | $15.02M derived: sum of 2 quarters · filed 2024-12-26 | $21.83M derived: sum of 3 quarters · filed 2024-12-26 | $28.58M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2021-12-31 | $8.14M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $14.95M derived: sum of 2 quarters · filed 2024-12-26 | $21.70M derived: sum of 3 quarters · filed 2024-12-26 | $28.38M 10-K/A · filed 2024-12-26 | $27.98M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $6.81M 10-Q · filed 2022-11-09 | $13.56M derived: sum of 2 quarters · filed 2022-11-09 | $20.24M 10-Q · filed 2022-11-09 | $26.46M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $6.75M 10-Q · filed 2022-08-08 | $13.44M 10-Q · filed 2022-08-08 | $19.65M derived: sum of 3 quarters · filed 2022-08-08 | $25.03M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $6.68M 10-Q · filed 2022-05-10 | $12.90M derived: sum of 2 quarters · filed 2022-05-10 | $18.28M derived: sum of 3 quarters · filed 2022-05-10 | $22.59M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $6.22M 10-K · filed 2021-03-05 | $11.59M derived: sum of 2 quarters · filed 2021-11-04 | $15.91M derived: sum of 3 quarters · filed 2021-11-04 | $20.17M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $5.38M 10-Q · filed 2021-11-04 | $9.69M derived: sum of 2 quarters · filed 2021-11-04 | $13.96M 10-Q · filed 2021-11-04 | $18.36M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $4.31M 10-Q · filed 2021-08-05 | $8.58M 10-Q · filed 2021-08-05 | $12.98M derived: sum of 3 quarters · filed 2021-08-05 | $16.90M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $4.27M 10-Q · filed 2021-05-06 | $8.67M derived: sum of 2 quarters · filed 2021-05-06 | $12.59M derived: sum of 3 quarters · filed 2021-05-06 | $16.61M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $4.40M 10-K · filed 2021-03-05 | $8.32M derived: sum of 2 quarters · filed 2021-03-05 | $12.34M derived: sum of 3 quarters · filed 2021-03-05 | $16.19M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $3.92M 10-K · filed 2021-03-05 | $7.94M derived: sum of 2 quarters · filed 2021-03-05 | $11.79M 10-Q · filed 2020-11-06 | $15.84M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | $4.02M 10-K · filed 2021-03-05 | $7.87M 10-Q · filed 2020-08-04 | $11.91M derived: sum of 3 quarters · filed 2021-03-05 | $16.32M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | $3.85M 10-K · filed 2021-03-05 | $7.90M derived: sum of 2 quarters · filed 2021-03-05 | $12.31M derived: sum of 3 quarters · filed 2021-03-05 | $16.01M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | $4.04M 10-K · filed 2020-03-13 | $8.46M derived: sum of 2 quarters · filed 2020-03-13 | $12.16M derived: sum of 3 quarters · filed 2020-03-13 | $15.80M 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | $4.41M 10-K · filed 2020-03-13 | $8.12M derived: sum of 2 quarters · filed 2020-03-13 | $11.76M 10-Q · filed 2019-11-08 | $15.69M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | $3.71M 10-K · filed 2020-03-13 | $7.35M 10-Q · filed 2019-08-06 | $11.28M derived: sum of 3 quarters · filed 2020-03-13 | $15.50M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-03-31 | $3.64M 10-K · filed 2020-03-13 | $7.57M derived: sum of 2 quarters · filed 2020-03-13 | $11.79M derived: sum of 3 quarters · filed 2020-03-13 | $15.70M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | $3.93M 10-K · filed 2019-03-18 | $8.15M derived: sum of 2 quarters · filed 2019-03-18 | $12.05M derived: sum of 3 quarters · filed 2019-03-18 | $16.30M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $4.22M 10-K · filed 2019-03-18 | $8.13M derived: sum of 2 quarters · filed 2019-03-18 | $12.38M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $3.90M 10-K · filed 2019-03-18 | $8.15M 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | $4.25M 10-K · filed 2019-03-18 | |||||||
| 2016-12-31 | $16.99M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |